ID: ALA5076868

Max Phase: Preclinical

Molecular Formula: C15H14O4

Molecular Weight: 258.27

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)(CC(=O)O)C1=CC(=O)c2ccccc2C1=O

Standard InChI:  InChI=1S/C15H14O4/c1-15(2,8-13(17)18)11-7-12(16)9-5-3-4-6-10(9)14(11)19/h3-7H,8H2,1-2H3,(H,17,18)

Standard InChI Key:  HKKSHBDPWFKKBF-UHFFFAOYSA-N

Associated Targets(Human)

Quinone reductase 1 1746 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 258.27Molecular Weight (Monoisotopic): 258.0892AlogP: 2.49#Rotatable Bonds: 3
Polar Surface Area: 71.44Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.91CX Basic pKa: CX LogP: 2.05CX LogD: -1.16
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.90Np Likeness Score: 0.62

References

1. Gong Q, Yang F, Hu J, Li T, Wang P, Li X, Zhang X..  (2021)  Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics.,  224  [PMID:34303080] [10.1016/j.ejmech.2021.113707]

Source